key: cord-0975657-2nza1i56 authors: Fadare, Olawale; Yakubu, Timothy; Emerenini, Franklin; Dare, Babafemi; Ijaiya, Mukhtar; Ogundare, Yemisi; Atuma, Emmanuel; Brickson, Kate; Strachan, Molly; Curran, Kelly; Fayorsey, Ruby title: Sustaining Early Infant Diagnosis of HIV During Coronavirus Disease 2019 Pandemic: Experience Collecting Dry Blood Spots Samples at Home From HIV-exposed Infants in Nigeria date: 2021-08-31 journal: Pediatr Infect Dis J DOI: 10.1097/inf.0000000000003306 sha: ce8fc33eebb6a3188c80e403ab0369d137379fe5 doc_id: 975657 cord_uid: 2nza1i56 nan The authors have no funding or conflicts of interest to disclose. O.F. and T.Y. are cofirst authors. D espite advances in prevention of mother to child transmission (PMTCT) of HIV, 160,000 new pediatric HIV infections were reported in 2020. 1 Vertical transmission of HIV in Nigeria remains high at 22%, with 37,000 new infections among children 0-14 years annually. 2 In Nigeria, access to early infant diagnosis (EID) has improved significantly; however, only 27% of HIV-exposed infants received an HIV test by 2 months of age in 2019. 3 EID programs require mothers to bring their infants to the health facility for testing. However, the global coronavirus disease 2019 (COVID-19) pandemic movement restrictions necessitated changes to the PMTCT service delivery model for infant follow-up to ensure uninterrupted service delivery. Nigeria reported its first COVID-19 case on February 27, 2020. 4 By March, a mandatory lock down with subsequent movement restrictions limited access to health facilities for nonemergency presentations including PMTCT services. 4 The Reaching Impact Saturation and Epidemic (RISE) Control program, which currently provides comprehensive HIV prevention, care and treatment services to over 82,000 recipients of care, rapidly pivoted to a community service delivery model to ensure uninterrupted access to HIV services. To circumvent the challenges faced by mothers and caregivers in accessing health facilities during the COVID-19 lockdown period, RISE deployed trained nurses to collect dried blood spot (DBS) samples for HIV viral load and EID in the communities where children, infants and their caregivers live. EID samples were collected by trained nurses in the home and transported to the health facility for onward transportation to regional labs. When sample collection was not feasible in the home, caregivers were escorted to the nearest health facility for sample collection. Case managers also provided antiretroviral drug refills for recipients of care in the community including antiretroviral prophylaxis refills for infants. Prelock down (October 2019 to March 2020), RISE collected 690 samples of which 57% (393/690) were collected within 2 months of birth with average turnaround time of 30 days. Postlock down (April to September 2020), 634 samples were collected of which 60% (379/634) were within 2 months of birth while maintaining an average turnaround time of 34 days. Regarding actual tests done, prelock down tests were done for 75% of samples for infants <2 months (n = 295) with 1.0 % positivity rate, while postlock down, 77% (n = 291) were tested with 0.3% positivity. Early results from the RISE program have shown that DBS specimens for HIV diagnosis in infants can be safely collected at home while maintaining specimen integrity and delivery of results back to caregivers. Several adaptations have been made to HIV programming to improve service delivery for HIV-infected pregnant, breastfeeding women, infants, children and adolescents. 4 We propose that HIV programs consider implementing home-based DBS collection to increase access to timely EID services for HIV-exposed infants both as an adaption during the COVID-19 pandemic and as an enduring solution thereafter. To the Editors: M ultisystem inflammatory syndrome in children (MIS-C) is a new disease entity seen 3-4 weeks post-severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) exposure (symptomatic or asymptomatic) and has predominant cardiac and gastrointestinal system involvement. 1 Ventricular dysfunction, coronary dilatation, valvulitis and pericardial effusion have been reported as prominent cardiac findings in MIS-C. 2, 3 We describe a teenager with MIS-C, who presented with myopericarditis and acute pericardial tamponade, requiring urgent surgical pericardiostomy and drainage. A 13-year-old girl came with a history of intermittent high-grade fever for 1 week, nausea and vomiting for 3 days and swelling of hands and feet for 2 days. She had a history of SARS-CoV-2 exposure 1 month back but was asymptomatic then. On admission, she was febrile, tachypneic, tachycardiac with a regular pulse that varied in intensity with the respiratory cycle, concerning for pulsus paradoxus, had hypotension, engorged neck veins, facial puffiness and edema over hands and feet. On auscultation, air entry was decreased bilaterally in both lower zones and heart sounds were distant. There was no murmur. Liver was palpable, and the umbilicus was everted. Her reverse transcriptase polymerase chain reaction test for SARS-CoV-2 was negative on admission, and anti-SARS-CoV-2 IgG antibodies were positive. Blood investigations showed increased inflammatory markers (Fig. 1) . Chest radiogram showed cardiomegaly and blunted costophrenic angles bilaterally (Fig. 1A) . Echocardiography showed a structurally normal heart but massive pericardial effusion with right atrial and ventricular free wall collapse in diastole, normal biventricular function and bilateral pleural effusion ( Fig. 1B and C) . In view of both pleural and pericardial effusions, she underwent urgent surgical "wide anterior pericardiectomy" with bilateral intercostal tube drainage, and 650 mL of transudative pericardial fluid was drained. Epicardium and pericardium were intense red colored, and pericardial biopsy confirmed acute inflammation ( Fig. 1D and E) . She received intravenous immunoglobulin and highdose intravenous steroids and showed clinical and hemodynamic improvement within 48 hours. She was discharged after 1 week of drain removal, on tapering doses of oral steroids and aspirin. At 1-month follow-up, she was asymptomatic and there was no pericardial collection on echocardiography evaluation. Pericardial involvement in the acute coronavirus disease 2019 may not always be associated myocardial involvement and can rarely present as tamponade requiring drainage. 4 Pericardial involvement in MIS-C has also been known; however, in a recent study, only 20% of children presenting with acute cardiovascular manifestations had associated mild-to-moderate pericardial effusion on echocardiogram, and none had severe effusion. 2 MIS-C presenting with pericardial tamponade requiring emergency pericardiocentesis has not been reported. Our case not only shows a rare presentation of MIS-C but also highlights the possibility of surgical intervention in the management of MIS-C. Shock in MIS-C can have multiple reasons, of which, although rare, pericardial tamponade should also be considered. Sinus bradycardia in children treated with remdesi-REFERENCES Joint United Nations Program on HIV/AIDS UNAIDS. Start Free Stay Free AIDS Free Epidemiologic response to the first case of COVID-19 in Nigeria Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 AEPC COVID-19 Rapid Response Team*. Acute cardiovascular manifestations in 286 children with multisystem inflammatory syndrome associated with COVID-19 infection in Europe Acute heart failure in multisystem inflammatory syndrome in children in the context of Global SARS-CoV-2 pandemic Pericardial diseases in COVID19: a contemporary review The authors thank Dr Ashwini Mane-Patil, MD, Pathologist at Aster Aadhar Hospital, Kolhapur, for kindly providing the photomicrographs of pericardial biopsy histopathology slides.